Transaction DateRecipientSharesTypePriceValue
15th January 2021Ernest Mario41,216Exercise of in-the-money or at-the-money derivatives securities (usually options)$2.27$93,560.32
2nd December 2020Anthony Y Sun7,878Open or private sale$51.67$407,021.60
2nd December 2020Anthony Y Sun6,283Open or private sale$52.70$331,122.90
2nd December 2020Anthony Y Sun3,411Open or private sale$49.79$169,838.12
2nd December 2020Anthony Y Sun9,222Open or private sale$50.90$469,361.07
24th November 2020Anthony Y Sun100Open or private sale$47.56$4,756.00
24th November 2020Anthony Y Sun5,831Open or private sale$46.21$269,424.27
24th November 2020Anthony Y Sun5,455Open or private sale$46.68$254,663.95
23rd November 2020Anthony Y Sun1,712Open or private sale$47.19$80,791.51
23rd November 2020Anthony Y Sun13,696Open or private sale$46.45$636,128.52
Eyenovia logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.

Edenovia, Inc. engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine.

Ticker: EYEN
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1682639
Employees: 24
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags